Actively Recruiting

Phase 2
Age: 18Years +
MALE
NCT06610825

Castrate Resistant Prostate Cancer Enhertu Therapy

Led by Washington D.C. Veterans Affairs Medical Center · Updated on 2026-04-13

60

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

Sponsors

W

Washington D.C. Veterans Affairs Medical Center

Lead Sponsor

D

Daiichi Sankyo

Collaborating Sponsor

AI-Summary

What this Trial Is About

Use of Enhertu as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma.

CONDITIONS

Official Title

Castrate Resistant Prostate Cancer Enhertu Therapy

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pathologically confirmed adenocarcinoma of the prostate
  • Diagnosis of metastatic castration-resistant prostate cancer (mCRPC)
  • Documented progression on androgen deprivation and novel hormonal agents, with or without progression on taxane containing regimen
  • Ongoing androgen deprivation therapy to maintain serum testosterone levels below 50 ng/dL
  • Availability of formalin fixed paraffin embedded tumor tissue for HER2 immunohistochemistry
  • Life expectancy of at least 6 months
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
  • Left ventricular ejection fraction (LVEF) of at least 50%
  • Adequate blood clotting function
  • Adequate organ and bone marrow function
  • Adequate renal function
  • Adequate hepatic function
Not Eligible

You will not qualify if you...

  • History of interstitial lung disease or pneumonitis requiring steroids
  • Significant coronary vascular disease
  • Previous exposure to HER2 targeted therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington DC VAMC

Washington D.C., District of Columbia, United States, 20422

Actively Recruiting

Loading map...

Research Team

A

Asha Escobar

CONTACT

M

Martha Antonio

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here